Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care

Rhea-AI Summary

Amwell (NYSE: AMWL) has announced the addition of Vida Health to its clinical programs portfolio, expanding its virtual cardiometabolic care offerings. The new program, Amwell Cardiometabolic Care Powered by Vida, will provide obesity and diabetes care services, including GLP-1s and anti-obesity medications, through Amwell's platform to health plans and employers.

The program will offer personalized care considering social factors like food security, financial barriers, and cultural norms. Vida's services will integrate with Amwell's existing virtual primary care, urgent care, and behavioral health programs. The partnership aims to address the significant healthcare challenge of obesity, which affects over 40% of American adults and, combined with diabetes, costs the U.S. healthcare system more than $500 billion annually.

The collaboration focuses on delivering value-based, outcomes-driven care through lifestyle interventions and Medical Nutrition Therapy, providing members with a unified entry point for clinical and behavioral health support.

Positive

• Integration expands Amwell's service offerings in the high-demand obesity and diabetes care market
• Addresses a $500 billion healthcare market opportunity
• Value-based, outcomes-driven model ensures accountability and measurable results
• Unified platform reduces member friction and improves accessibility to multiple healthcare services

Negative

• None.

Vida to offer cardiometabolic solutions including GLP-1s and other anti-obesity medications on the Amwell platform

BOSTON and SAN FRANCISCO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced that Vida Health, a leader in virtual cardiometabolic care, is now part of the clinical programs portfolio on the Amwell platform.

The program, Amwell Cardiometabolic Care Powered by Vida, will be available to Amwell’s expansive client footprint of health plans and employers. Clients will be able to offer their members access to a suite of cardiometabolic care, including obesity, diabetes prevention and management, and behavioral health support. The program will tailor care based on social factors such as food security, financial barriers, cultural norms, and beliefs. Vida’s services are available on the Amwell platform alongside existing virtual primary care, urgent care, behavioral health and other clinical programs in the Amwell ecosystem.

“We are thrilled to partner with Amwell,” said Joe Murad, CEO of Vida Health. “By leveraging our complementary capabilities, we’re making it easier than ever to provide members with personalized, high-touch care. Together, we’re working to reduce member friction, improve health outcomes at scale, and reduce costs.”

More than 40 percent of American adults struggle with obesity, a condition that increases the risk of developing diabetes, heart disease and cancer. Together, obesity and diabetes cost the U.S. healthcare system more than $500 billion a year.

Vida clinicians prescribe GLP-1s, other anti-obesity medications and lifestyle interventions like Medical Nutrition Therapy. These services are delivered through a value-based, outcomes-driven model that ensures accountability and measurable results.

“We’re pleased Vida is joining the growing number of third-party programs available through Amwell’s integrated clinical solutions portfolio. With this partnership, our health plan clients can offer members a single entry point to the clinical and behavioral health support they need for obesity care and related illnesses,” said Ido Schoenberg, Amwell chairman and CEO. “Vida’s programs adapt to the patient’s needs, resulting in a personalized, cost-effective way to achieving weight loss requirements while applying an evidence-based, step therapy approach.”   

Amwell’s clinical programs portfolio features virtual and digital care products from partners addressing various health conditions. The portfolio is part of the company’s platform and provides health plans with the technology to offer employers and members a unified and delightful entry point to a comprehensive and dynamic set of orchestrated clinical programs. The result is a personalized and reportable whole-person care model focused on improving health outcomes and driving efficiencies.

About Vida Health
Vida Health is a virtual obesity and metabolic center of excellence that provides personalized care for individuals with obesity and related conditions. Vida’s holistic approach combines human care with AI-powered insights to deliver lasting health outcomes and help prevent and manage chronic diseases. Vida serves members in all 50 states, offering services in both English and Spanish, and operates on a value-based pricing model, putting outcomes at the center of care. To learn more, visit www.Vida.com.

About Amwell
Amwell is a leading hybrid care delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.

©2025 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell ConvergeTM, CarepointTM and the Amwell logo are registered trademarks or trademarks of American Well Corporation.

FAQ

What new services will be available through AMWL's partnership with Vida Health?

The partnership will offer cardiometabolic care services, including GLP-1s, anti-obesity medications, diabetes prevention and management, and behavioral health support through the Amwell platform.

How large is the market opportunity for AMWL's new cardiometabolic care program?

The program addresses obesity and diabetes care, which together cost the U.S. healthcare system more than $500 billion annually, with over 40% of American adults struggling with obesity.

What unique features does AMWL's Cardiometabolic Care program powered by Vida offer?

The program offers personalized care based on social factors like food security, financial barriers, and cultural norms, while providing integrated access to virtual primary care, urgent care, and behavioral health services.

How will AMWL's partnership with Vida Health benefit health plan clients?

Health plan clients will be able to offer members a single entry point to comprehensive clinical and behavioral health support for obesity care and related illnesses through a value-based, outcomes-driven model.